NewsRx

Search our medical news database

Colon Cancer

Specialty reference laboratory collaborates in colon cancer research

Published in Cancer Weekly, July 20th, 2004

Targeted Molecular Diagnostics (TMD) announced new collaborative work in colon cancer with researchers at University of Texas MD Anderson Cancer Center.

TMD has been working along with the laboratory of Khandan Keyomarsi, studying cell cycle regulators in breast cancer. Work from this venture, which was published in the New England Journal of Medicine in November of 2002, highlighted the potential prognostic significance of cyclin E in patients with Stage I-III breast cancer.

In this latest collaboration, investigators at MDACC and TMD will be studying the relevance of cyclin E in predicting the outcome for patients undergoing liver surgery...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook